REGULATED PRESS RELEASE published on 06/10/2024 at 17:35, 5 months 12 days ago Disclosure of transactions in own shares on June 3 to June 7, 2024
BRIEF published on 06/07/2024 at 17:40, 5 months 15 days ago Disclosure of EURAZEO's Shares and Voting Rights as of May 31, 2024 Voting Rights Shares EURAZEO Financial Disclosure AMF Regulation
REGULATED PRESS RELEASE published on 06/07/2024 at 17:35, 5 months 15 days ago Disclosure of the number of shares and the total number of voting rights as of May 31, 2024 Disclosure of the number of shares and the total number of voting rights for EURAZEO SE as of May 31, 2024 in compliance with regulations. Eurazeo is a leading European investment group managing diversified assets Voting Rights Shares Investment Group Regulations Eurazeo SE
BRIEF published on 06/06/2024 at 17:50, 5 months 16 days ago Eurazeo Announces Grape Hospitality’s Exclusive Agreement for the Sale of 23 Hotels Real Estate EURAZEO Investment Hotel Sale Grape Hospitality
REGULATED PRESS RELEASE published on 06/06/2024 at 17:45, 5 months 16 days ago Eurazeo announces the signing by Grape Hospitality of an exclusivity agreement for the sale of 23 hotels Eurazeo's subsidiary, Grape Hospitality, to sell 23 hotels in France to hotel operator and real estate fund. Transaction to enhance asset value and focus on mid-range and upscale segments EURAZEO France Hotel Sale Grape Hospitality Asset Enhancement
REGULATED PRESS RELEASE published on 06/03/2024 at 17:35, 5 months 19 days ago Disclosure of transactions in own shares on May 27 to May 31, 2024
BRIEF published on 05/31/2024 at 08:06, 5 months 22 days ago Eurazeo Announces Sale of Stake in MCH Private Equity Private Equity EURAZEO Investment Stake Sale MCH Private Equity
REGULATED PRESS RELEASE published on 05/31/2024 at 08:01, 5 months 22 days ago Eurazeo announces the sale of its stake in MCH Private Equity Eurazeo announces the sale of 25% stake in MCH Private Equity, retaining EUR 80 million investment. Finalization of the process subject to regulatory approval EURAZEO Investment Regulatory Approval Sale MCH Private Equity
BRIEF published on 05/28/2024 at 08:35, 5 months 25 days ago EURAZEO Announces Sale of Its Stake in LumApps EURAZEO Employee Experience Stake Sale LumApps Bridgepoint
REGULATED PRESS RELEASE published on 05/28/2024 at 08:30, 5 months 25 days ago EURAZEO ANNOUNCES THE SALE OF ITS STAKE IN LUMAPPS Eurazeo and partners sell stake in LumApps, leading Employee Experience platform, to Bridgepoint for over €210 million. LumApps revenue grows 15x, with a presence in the US and profitability since 2023 EURAZEO Strategic Investment Employee Experience LumApps Bridgepoint
Published on 11/22/2024 at 18:45, 2 hours 37 minutes ago CORRECTING and REPLACING the Not-So-Secret Lives of REAL "Mormon" Wives - the Eye-Opening New Book From Cedar Fort Publishing & Media - is Now Available for Purchase, Just in Time for Christmas
Published on 11/22/2024 at 16:00, 5 hours 22 minutes ago Manimal Tales Unveils Two New Personalized Christmas-Themed Books to Spread Holiday Magic and Joy!
Published on 11/22/2024 at 15:55, 5 hours 27 minutes ago Independent Proxy Advisory Firm ISS Recommends Signal Gold Shareholders Vote for Arrangement Resolution and Private Placement Resolution
Published on 11/22/2024 at 15:15, 6 hours 7 minutes ago Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Published on 11/22/2024 at 14:45, 6 hours 37 minutes ago Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs
Published on 11/22/2024 at 18:14, 3 hours 7 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 3 hours 28 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 4 hours 26 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 5 hours 21 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 1 day 14 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 2 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 3 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 3 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024